The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

BACKGROUND: It is frequently asked whether chemotherapy can still play a role in metastatic melanoma considering the effectiveness of the available drugs today, including antiCTLA4/antiPD1 immunotherapy and antiBRAF/antiMEK inhibitors. However, only approximately half of patients respond to these dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guida, Michele, Tommasi, Stefania, Strippoli, Sabino, Natalicchio, Maria Iole, De Summa, Simona, Pinto, Rosamaria, Cramarossa, Antonio, Albano, Anna, Pisconti, Salvatore, Aieta, Michele, Ridolfi, Ruggiero, Azzariti, Amalia, Guida, Gabriella, Lorusso, Vito, Colucci, Giusepe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946485/
https://www.ncbi.nlm.nih.gov/pubmed/29747595
http://dx.doi.org/10.1186/s12885-018-4479-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946485/
https://www.ncbi.nlm.nih.gov/pubmed/29747595
http://dx.doi.org/10.1186/s12885-018-4479-2

Ejemplares similares